Spinal α3β2* nicotinic acetylcholine receptors tonically inhibit the transmission of nociceptive mechanical stimuli

Brain Research

Volumn 1229, Issue , 2008, Pages 118-124

  Young, Tracey ^a   Wittenauer, Shannon ^a   McIntosh, J Michael ^b,c   Vincler, Michelle ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Conotoxin; C fiber; Glutamate; Hyperalgesia; Pain

Indexed keywords

ALPHA CONOTOXIN MII; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINIC RECEPTOR; ALPHA-CONOTOXIN MII; AMINO ACID RECEPTOR BLOCKING AGENT; CONOTOXIN; DIZOCILPINE MALEATE; NICOTINIC RECEPTOR ALPHA3BETA2; NICOTINIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; MALE; MECHANICAL STIMULATION; NERVE LIGATION; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PARASYMPATHETIC NERVE; PRIORITY JOURNAL; RADIOASSAY; RAT; RECEPTOR AFFINITY; SPINAL NERVE; ANIMAL; ANIMAL BEHAVIOR; AREA UNDER THE CURVE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; HEMISPHERIC DOMINANCE; HYPERALGESIA; LIGATION; METABOLISM; METHODOLOGY; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOLOGY; PERIPHERAL NEUROPATHY; SPRAGUE DAWLEY RAT; STIMULATION; TIME;

RATTUS;

ANIMALS; AREA UNDER CURVE; BEHAVIOR, ANIMAL; CONOTOXINS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FUNCTIONAL LATERALITY; HYPERALGESIA; LIGATION; MALE; NICOTINIC ANTAGONISTS; PAIN MEASUREMENT; PAIN THRESHOLD; PERIPHERAL NERVOUS SYSTEM DISEASES; PHYSICAL STIMULATION; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SPINAL NERVES; TIME FACTORS;

EID: 49849093400     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.06.086     Document Type: Article

References (27)

1. Abdin M.J., Morioka N., Morita K., Kitayama T., Kitayama S., Nakashima T., and Dohi T. Analgesic action of nicotine on tibial nerve transection (TNT)-induced mechanical allodynia through enhancement of the glycinergic inhibitory system in spinal cord. Life Sci. 80 (2006) 9-16
2. Azam L., Yoshikami D., and McIntosh J.M. Amino acid residues that confer high selectivity of the alpha 6 nicotinic acetylcholine receptor subunit to alpha-conotoxin MII[S4A;E11A;L15A]. J. Biol. Chem. 283 (2008) 11625-11632
3. Cartier G.E., Yoshikami D., Gray W.R., Luo S., Olivera B.M., and McIntosh J.M. A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors. J. Biol. Chem. 271 (1996) 7522-7528
4. Champtiaux N., Han Z.Y., Bessis A., Rossi F.M., Zoli M., Marubio L., McIntosh J.M., and Changeux J.P. Distribution and Pharmacology of alpha 6-Containing Nicotinic Acetylcholine Receptors Analyzed with Mutant Mice. J. Neurosci. 22 (2002) 1208-1217
5. Jensen A.A., Frolund B., Liljefors T., and Krogsgaard-Larsen P. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J. Med. Chem. 48 (2005) 4705-4745
6. Khan I., Osaka H., Stanislaus S., Calvo R.M., Deerinck T., Yaksh T.L., and Taylor P. Nicotinic acetylcholine receptor distribution in relation to spinal neurotransmission pathways. J. Comp. Neurol. 467 (2003) 44-59
7. Khan I.M., Marsala M., Printz M.P., Taylor P., and Yaksh T.L. Intrathecal nicotinic agonist-elicited release of excitatory amino acids as measured by in vivo spinal microdialysis in rats. J. Pharmacol. Exp. Ther. 278 (1996) 97-106
8. Khan I.M., Stanislaus S., Zhang L., Taylor P., and Yaksh T.L. A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception. J. Pharmacol. Exp. Ther. 297 (2001) 230-239
9. Khan I.M., Wennerholm M., Singletary E., Polston K., Zhang L., Deerinck T., Yaksh T.L., and Taylor P. Ablation of primary afferent terminals reduces nicotinic receptor expression and the nociceptive responses to nicotinic agonists in the spinal cord. J. Neurocytol. 33 (2004) 543-556
10. Khan I.M., Yaksh T.L., and Taylor P. Epibatidine binding sites and activity in the spinal cord. Brain Res. 753 (1997) 269-282
11. Khan I.M., Wart C.V., Singletary E.A., Stanislaus S., Deerinck T., Yaksh T.L., and Printz M.P. Elimination of rat spinal substance P receptor bearing neurons dissociates cardiovascular and nocifensive responses to nicotinic agonists. Neuropharmacology 54 (2008) 269-279
12. Kim S.H., and Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
13. Lukas R.J., Changeux J.P., Le Novere N., Albuquerque E.X., Balfour D.J., Berg D.K., Bertrand D., Chiappinelli V.A., Clarke P.B., Collins A.C., Dani J.A., Grady S.R., Kellar K.J., Lindstrom J.M., Marks M.J., Quik M., Taylor P.W., and Wonnacott S. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol. Rev. 51 (1999) 397-401
14. McIntosh J.M., Azam L., Staheli S., Dowell C., Lindstrom J.M., Kuryatov A., Garrett J.E., Marks M.J., and Whiteaker P. Analogs of α-conotoxin MII are selective for α6-containing nicotinic acetylcholine receptors. Mol. Pharmacol. 65 (2004) 944-952
15. Milligan E.D., Hinde J.L., Mehmert K.K., Maier S.F., and Watkins L.R. A method for increasing the viability of the external portion of lumbar catheters placed in the spinal subarachnoid space of rats. Journal of Neuroscience Methods 90 (1999) 81-86
16. Pan H.L., Khan G.M., Alloway K.D., and Chen S.R. Resiniferatoxin induces paradoxical changes in thermal and mechanical sensitivities in rats: mechanism of action. J. Neurosci. 23 (2003) 2911-2919
17. Randall L.O., and Selitto J.J. A method for measurement of analgesic activity on inflamed tissueArch. Int. Pharmacodyn. CXI (1957) 409-419
18. Rashid M.H., Furue H., Yoshimura M., and Ueda H. Tonic inhibitory role of alpha4beta2 subtype of nicotinic acetylcholine receptors on nociceptive transmission in the spinal cord in mice. Pain 125 (2006) 125-135
19. Rashid M.H., and Ueda H. Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism. Brain Res. 953 (2002) 53-62
20. Salminen O., Whiteaker P., Grady S.R., Collins A.C., McIntosh J.M., and Marks M.J. The subunit composition and pharmacology of [alpha]-conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay. Neuropharmacology 48 (2005) 696-705
21. Storkson R.V., Kjorsvik A., Tjolsen A., and Hole K. Lumbar catheterization of the spinal subarachnoid space in the rat. J. Neurosci. Methods 65 (1996) 167-172
22. Taiwo Y.O., Coderre T.J., and Levine J.D. The contribution of training to sensitivity in the nociceptive paw-withdrawal test. Brain Res. 487 (1989) 148-151
23. Takeda D., Nakatsuka T., Papke R., and Gu J.G. Modulation of inhibitory synaptic activity by a non-alpha4beta2, non-alpha7 subtype of nicotinic receptors in the substantia gelatinosa of adult rat spinal cord. Pain 101 (2003) 13-23
24. Vincler M., and Eisenach J.C. Plasticity of spinal nicotinic acetylcholine receptors following spinal nerve ligation. Neurosci. Res. 48 (2004) 139-145
25. Wang F., Gerzanich V., Wells G.B., Anand R., Peng X., Keyser K., and Lindstrom J. Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits. J. Biol. Chem. 271 (1996) 17656-17665
26. 125I-a-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain. Mol. Pharmacol. 57 (2000) 913-925
27. Yang L., Zhang F.X., Huang F., Lu Y.J., Li G.D., Bao L., Xiao H.S., and Zhang X. Peripheral nerve injury induces trans-synaptic modification of channels, receptors and signal pathways in rat dorsal spinal cord. Eur. J. Neurosci. 19 (2004) 871-883